Dr. Velenosi received his PhD in pharmacology and toxicology from Western University. As a graduate student, he used state-of-the-art metabolomics analysis to identify a novel metabolic biomarker of kidney function in patients with chronic kidney disease. He then joined the Laboratory of Metabolism at the National Cancer Institute (National Institutes of Health) as a postdoctoral fellow, which was supported by the Canadian Institutes of Health Research Fellowship. There, he began his research vision by developing a novel approach to using metabolic biomarkers as a path for personalizing therapy and improving outcomes for cancer patients. He is currently an assistant professor in the UBC Faculty of Pharmaceutical Sciences.
Laboratory of Metabolism
National Institutes of Health
PhD in Pharmacology & Toxicology